AUG 23, 2019 7:29 AM PDT

Making Opioids Safer

WRITTEN BY: Amanda Mikyska

The opioid crisis results in 130 American deaths every day, and both prescribed and synthetic opioids are at the core of the epidemic.  Any other drug that posed such liability would likely be taken off the market, but opioids are unmatched at tackling the most basic aliment: pain.  

Opioids are so effective at mitigating pain because they target "Micro-Opioid Receptors" (MORs), located in the area of the brain stem called the Periaqueductal Gray (PAG).  The PAG is responsible for inhibiting pain signals transmitted to the brain, acting a brake so that the brain is not inundated with pain signals.  

Scientists at Scripps Research are trying to combat patient pain and limit the dangers of opioids.  By following the mechanism of opioids in the brain, the researchers were able to identify genes that dial the effects of the drug.  

The researchers started with a genomic assay to find all genes involved in the body's response to opioid exposure.  This "unbiased" search resulted in a list of specific genes for the team to monitor during exposure to opioids.  

The nematode worm, Caenorhabditis elegans, was used to test the response to opioids.  C. elegans does not naturally have any response to opioid exposure, so the worms were modified with the addition of such response genes.  The genetic modification worked because the worms had a familiar response to opioid drugs:  decreased pain, heavy dependence, and severe withdrawal symptoms.  

C. elegans source:  Society for Mucosal Immunology.

 

Next, the researchers monitored genes related to the physical response of opioids and isolated a protein called FRPR-13.  The equivalent in humans, GPR139, is made simultaneously with the MOR group of receptors.  However, the expression of GPR139 inhibits MORs, blocking opioids from activating the receptors.  

For example, mice that produce excess GPR139 and are dependent on opioids, choose to stop taking the drug because the receptors cannot signal a need for it.  Removal of GPR139 amplified addictiveness and pain-killing effect of opioids, but also eliminated withdrawal symptoms.  

Researchers believe eliminating GPR139 could be the key to making opioids safer to use.  The elimination of the protein not only makes opioids a better pain killer but without any withdrawal symptoms, the barriers to ending addiction disappear.

Scientists hope this research will lead to a solution to end the opioid epidemic and provide a powerful alternative for legitimate medical pain.  Understanding the mechanisms of pain inhibition, MORs, and GPR139 is a big step in solving these problems.  

 

Sources: Centers for Disease Control and Prevention, Nueroscientifically Challenged, ScienceDaily, Science  

About the Author
  • Amanda graduated from the University of Massachusetts Boston with a degree in Biology. After working in research on creating biochemicals from genetically engineered yeast, she started freelance science writing while traveling the world. Now, Amanda is a Lab Manager and Research Assistant at the the University of Central Florida, studying the molecular phylogeny of parasitic wasps. She writes about the latest research in Neuroscience, Genetics & Genomics, and Immunology. Interested in working on solutions for food/water security, sustainable fuel, and sustainable farming. Amanda is an avid skier, podcast listener, and has run two triathlons.
You May Also Like
AUG 05, 2020
Coronavirus
Age-old Immune Components Affecting COVID-19 Severity
AUG 05, 2020
Age-old Immune Components Affecting COVID-19 Severity
One of the most unsettling aspects of the coronavirus pandemic is the wide range of severity those affected seem to expe ...
AUG 19, 2020
Cell & Molecular Biology
Mild COVID-19 Cases Induce an Immune Cell Response
AUG 19, 2020
Mild COVID-19 Cases Induce an Immune Cell Response
As the pandemic virus, SARS-CoV-2 continues to cause tens of thousands of new cases of COVID-19 every day in the United ...
SEP 16, 2020
Immunology
Depression, but Not Anxiety, Causes Inflammation and Metabolic Imbalances
SEP 16, 2020
Depression, but Not Anxiety, Causes Inflammation and Metabolic Imbalances
Scientists have discovered that depressed individuals show higher levels of inflammation as well as elevated fat concent ...
SEP 11, 2020
Immunology
Study Reveals Tumor Defense Mechanism... And How to Beat It
SEP 11, 2020
Study Reveals Tumor Defense Mechanism... And How to Beat It
  P53 is an infamous process gene at the core of the development of tumors.  When P53  functional, it pau ...
OCT 13, 2020
Immunology
Why Halloween Is Extra Scary for Kids With Peanut Allergies
OCT 13, 2020
Why Halloween Is Extra Scary for Kids With Peanut Allergies
A recent study showed that there is an 85 percent spike in peanut allergy anaphylaxis cases on Halloween. The study, per ...
NOV 16, 2020
Immunology
Australian COVID-19 vaccine is promising and could be released next year
NOV 16, 2020
Australian COVID-19 vaccine is promising and could be released next year
Pharmaceutical companies worldwide are racing to develop a COVID-19 vaccine that will hopefully end this pandemic and he ...
Loading Comments...